Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Goergen KM, Grill DE, Chen MH, Hao L, Icenogle J, Poland GA.

Vaccine. 2019 Nov 12. pii: S0264-410X(19)31511-7. doi: 10.1016/j.vaccine.2019.11.004. [Epub ahead of print]

PMID:
31732325
2.

Sex Differences in Older Adults' Immune Responses to Seasonal Influenza Vaccination.

Voigt EA, Ovsyannikova IG, Kennedy RB, Grill DE, Goergen KM, Schaid DJ, Poland GA.

Front Immunol. 2019 Feb 27;10:180. doi: 10.3389/fimmu.2019.00180. eCollection 2019.

3.

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.

Hurley RM, Wahner Hendrickson AE, Visscher DW, Ansell P, Harrell MI, Wagner JM, Negron V, Goergen KM, Maurer MJ, Oberg AL, Meng XW, Flatten KS, De Jonge MJA, Van Herpen CD, Gietema JA, Koornstra RHT, Jager A, den Hollander MW, Dudley M, Shepherd SP, Swisher EM, Kaufmann SH.

Gynecol Oncol. 2019 Apr;153(1):127-134. doi: 10.1016/j.ygyno.2019.01.015. Epub 2019 Jan 25.

PMID:
30686551
4.

Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.

Haralambieva IH, Kennedy RB, Simon WL, Goergen KM, Grill DE, Ovsyannikova IG, Poland GA.

PLoS One. 2018 Jan 30;13(1):e0191812. doi: 10.1371/journal.pone.0191812. eCollection 2018.

5.

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review.

Mehner C, Oberg AL, Goergen KM, Kalli KR, Maurer MJ, Nassar A, Goode EL, Keeney GL, Jatoi A, Radisky DC, Radisky ES.

Genes Cancer. 2017 May;8(5-6):589-599. doi: 10.18632/genesandcancer.142.

6.

Transthoracic Echocardiography versus Computed Tomography for Ascending Aortic Measurements in Patients with Bicuspid Aortic Valve.

Park JY, Foley TA, Bonnichsen CR, Maurer MJ, Goergen KM, Nkomo VT, Enriquez-Sarano M, Williamson EE, Michelena HI.

J Am Soc Echocardiogr. 2017 Jul;30(7):625-635. doi: 10.1016/j.echo.2017.03.006. Epub 2017 May 10.

PMID:
28501375
7.

Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations.

Zimmermann MT, Kennedy RB, Grill DE, Oberg AL, Goergen KM, Ovsyannikova IG, Haralambieva IH, Poland GA.

Front Immunol. 2017 Apr 21;8:445. doi: 10.3389/fimmu.2017.00445. eCollection 2017.

8.

Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals.

Ovsyannikova IG, Oberg AL, Kennedy RB, Zimmermann MT, Haralambieva IH, Goergen KM, Grill DE, Poland GA.

Heliyon. 2016 May 6;2(5):e00098. doi: 10.1016/j.heliyon.2016.e00098. eCollection 2016 May.

9.

The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.

Kennedy RB, Simon WL, Gibson MJ, Goergen KM, Grill DE, Oberg AL, Poland GA.

Immunology. 2016 Jul;148(3):266-75. doi: 10.1111/imm.12599. Epub 2016 May 17.

10.

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.

Mehner C, Oberg AL, Kalli KR, Nassar A, Hockla A, Pendlebury D, Cichon MA, Goergen KM, Maurer MJ, Goode EL, Keeney GL, Jatoi A, Sahin-Tóth M, Copland JA, Radisky DC, Radisky ES.

Oncotarget. 2015 Nov 3;6(34):35737-54. doi: 10.18632/oncotarget.5927.

11.

Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults.

Kennedy RB, Tosh PK, Goergen KM, Grill DE, Oberg AL, Poland GA.

Vaccine. 2015 Jul 17;33(31):3682-8. doi: 10.1016/j.vaccine.2015.06.031. Epub 2015 Jun 16.

12.

The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.

Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, Oberg AL, Poland GA.

PLoS One. 2015 Mar 27;10(3):e0122282. doi: 10.1371/journal.pone.0122282. eCollection 2015.

13.

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.

Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ.

Gynecol Oncol. 2015 Apr;137(1):77-85. doi: 10.1016/j.ygyno.2015.01.539. Epub 2015 Jan 22.

14.

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, Wang C, Tyrer J, Song H, deFazio A, Johnatty SE, Doherty JA, Phelan CM, Sellers TA, Ramirez SM, Vitonis AF, Terry KL, Van Den Berg D, Pike MC, Wu AH, Berchuck A, Gentry-Maharaj A, Ramus SJ, Diergaarde B, Shen H, Jensen A, Menkiszak J, Cybulski C, Lubiłski J, Ziogas A, Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S, Despierre E, Garcia-Closas M, Yang H, Brinton LA, Spiewankiewicz B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A, Paddock LE, Orlow I, Lundvall L, Olson SH, Hogdall CK, Schwaab I, du Bois A, Harter P, Flanagan JM, Brown R, Paul J, Ekici AB, Beckmann MW, Hein A, Eccles D, Lurie G, Hays LE, Bean YT, Pejovic T, Goodman MT, Campbell I, Fasching PA, Konecny G, Kaye SB, Heitz F, Hogdall E, Bandera EV, Chang-Claude J, Kupryjanczyk J, Wentzensen N, Lambrechts D, Karlan BY, Whittemore AS, Culver HA, Gronwald J, Levine DA, Kjaer SK, Menon U, Schildkraut JM, Pearce CL, Cramer DW, Rossing MA, Chenevix-Trench G; AOCS group; ACS, Pharoah PD, Gayther SA, Ness RB, Odunsi K, Sucheston LE, Knutson KL, Goode EL.

Cancer Immunol Res. 2014 Apr;2(4):332-40. doi: 10.1158/2326-6066.CIR-13-0136. Epub 2014 Jan 27.

15.

Granzyme B ELISPOT assay to measure influenza-specific cellular immunity.

Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA.

J Immunol Methods. 2013 Dec 15;398-399:44-50. doi: 10.1016/j.jim.2013.09.007. Epub 2013 Sep 18.

16.

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.

Carlson AM, Maurer MJ, Goergen KM, Kalli KR, Erskine CL, Behrens MD, Knutson KL, Block MS.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1730-5. doi: 10.1158/1055-9965.EPI-12-1368. Epub 2013 Jul 22.

Supplemental Content

Loading ...
Support Center